CX Institutional’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357K Buy
4,921
+114
+2% +$8.21K 0.01% 569
2026
Q2
$340K Buy
4,807
+857
+22% +$46.3K 0.01% 582
2026
Q1
$206K Sell
3,950
-45
-1% -$2.7K 0.01% 709
2025
Q4
$235K Buy
3,995
+806
+25% +$49K 0.01% 653
2025
Q3
$177K Buy
3,189
+118
+4% +$6.32K 0.01% 728
2025
Q2
$158K Buy
3,071
+2,612
+569% +$131K 0.01% 689
2025
Q1
$27K Buy
+459
New +$31.1K ﹤0.01% 922
2022
Q3
– Sell
-52
Closed -$5K – 1061
2022
Q2
$5K Buy
+52
New +$4.87K ﹤0.01% 1040
2021
Q4
– Sell
-28
Closed -$3K – 833
2021
Q3
$3K Hold
28
– – ﹤0.01% 889
2021
Q2
$3K Hold
28
– – ﹤0.01% 891
2021
Q1
$3K Hold
28
– – ﹤0.01% 818
2020
Q4
$2K Hold
28
– – ﹤0.01% 829
2020
Q3
$2K Buy
28
+4
+17% +$260 ﹤0.01% 822
2020
Q2
$2K Buy
+24
New +$1.44K ﹤0.01% 768

Other funds holding TECH

CX Institutional's TECH Position: Q3 2026 in Review

CX Institutional increased its Bio-Techne (TECH) stake by 2.4% in Q3 2026, buying an estimated $8.21K and bringing the position to 4,921 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #569.

CX Institutional first reported a position in TECH in Q2 2020 and has held it in 14 quarters since. 15 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • CX Institutional held 4,921 shares of Bio-Techne worth $357K as of Q3 2026.
  • CX Institutional bought 114 Bio-Techne shares in Q3 2026, an estimated $8.21K.
  • Bio-Techne made up 0.01% of CX Institutional's portfolio in Q3 2026, its #569 holding.
  • CX Institutional first reported a position in Bio-Techne in Q2 2020 and has held it in 14 quarters since.
  • 15 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.